Nasus Pharma Ltd (NSRX) stock
NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
$2.66−0.21 (-7.32%)
Close on Nov 16, 2026Market cap $23.98MP/E –Yield –
Nasus Pharma total assets
Total assets on the balance sheet at the end of each period.
Nasus Pharma's total assets was $12.45M at Jun 30, 2026. For fiscal 2025 it was $5.00M, up 597.9% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.00M | +597.9% |
| FY2024 | Dec 31, 2024 | $717.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $12.45M | – |
| Q4 FY2025 | Dec 31, 2025 | $5.00M | – |
| Q2 FY2025 | Jun 30, 2025 | $639.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $717.00K | – |
See a number that looks wrong?